Search for:

The Cancer Letter on Facebook
The Cancer Letter on Twitter
The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Search for:

Home

About
Current Issue
- Past Issues
Podcast
- The Directors
Events
Job Board

Regulatory News

FDA cancels second ODAC in a row as two accelerated approval drugs are yanked by sponsors (and one still dangles)

December 03, 2021

Vol.47 No.44

By Alice Tracey

Posts navigation

Previous 1…56

Trending Stories

Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis
Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
As more people are surviving cancer, we must continue funding bold science

ABOUT

About The Cancer Letter

Accessibility Statement

SUBSCRIPTIONS

CONTACT

Submission guidelines

Advertise

Careers

SEE ALSO

Terms & Conditions

Scroll to top

Request Cancellation

Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.

SUBSCRIBE NOW

Subscriber content

SEARCH DATE

SEARCH TEXT

Cancel

Delete Account

Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below

Password

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Username or Email

Password

Remember Me Forgot Password?

Site license subscribers:
Log in with your IP | Register a sponsored account